Cerecor closes first tranche of $32 mln Series B
Cerecor has closed on the initial tranche of a $32 million Series B funding. New Enterprise Associates, Apple Tree Partners and MPM Capital led the round. Based in Baltimore, Cerecor is a biopharmaceutical firm focused on developing treatments for patients suffering from nervous system disorders.
21 July 2014•4 mins read
